Clinical Ophthalmology (Jun 2024)
Verteporfin Photodynamic Therapy for the Treatment of Chorioretinal Conditions: A Narrative Review
Abstract
Sunir J Garg,1 Majda Hadziahmetovic2 1Retina Service, Wills Eye Hospital, Philadelphia, PA, USA; 2Department of Ophthalmology, Duke University, Durham, NC, USACorrespondence: Sunir J Garg, Retina Service, Wills Eye Hospital, 840 Walnut Street, Suite 1020, Philadelphia, PA, 19107, USA, Tel +1-215-928-3444, Email [email protected] Majda Hadziahmetovic, Department of Ophthalmology, Duke University, 5321 Erwin Road, Durham, NC, 27710, USA, Tel +1-919-684-0275, Email [email protected]: Photodynamic therapy (PDT) with verteporfin involves intravenous administration of a photosensitizer followed by its laser light activation at the target site to inhibit aberrant choroidal vascularization. This narrative review provides an overview of the role verteporfin PDT plays in the management of chorioretinal conditions. A PubMed literature review of all English-language articles published through October 19, 2023, was conducted to identify relevant references. Verteporfin PDT has been shown to be safe and effective for the treatment of patients with choroidal neovascularization (CNV) due to neovascular age-related macular degeneration and is often used in combination with a vascular endothelial growth factor (VEGF) inhibitor. Additionally, patients with polypoidal choroidal vasculopathy, a subtype of neovascular age-related macular degeneration, also benefit from verteporfin PDT combined with a VEGF inhibitor for improving visual acuity. Verteporfin PDT has also been effective in treating patients with peripapillary CNV, as well as eyes with CNV due to ocular histoplasmosis and pathologic myopia. Reduced dose and/or fluence PDT protocols have been effective in patients with central serous chorioretinopathy while reducing adverse effects. In eyes with choroidal hemangioma, tumor regression and visual outcomes have been improved with verteporfin PDT treatment. Photodynamic therapy with verteporfin continues to play an important role in the management of chorioretinal conditions.Keywords: choroid, retina, macular degeneration, vascularization, VEGF inhibitor
